Review




Structured Review

Proteostasis Therapeutics pp2a inhibition
Pp2a Inhibition, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/pm41846138-108-4-0?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
pp2a inhibition - by Bioz Stars, 2026-08
86/100 stars

Images



Similar Products

86
Proteostasis Therapeutics pp2a inhibition
Pp2a Inhibition, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/pm41846138-108-4-0?v=Proteostasis+Therapeutics
Average 86 stars, based on 1 article reviews
pp2a inhibition - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology pp2a inhibition
Pp2a Inhibition, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/us12448421-725-9-5?v=Santa+Cruz+Biotechnology
Average 95 stars, based on 1 article reviews
pp2a inhibition - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Selleck Chemicals pp2a inhibition
a Western blots of total cell extract of RPE-1 wild type cells (WT) and RPE-1 CIP2A knock-out cells cells (ΔCIP2A) either Mock treated (-) or treated with the <t>PP2A</t> inhibitor LB-100. b GFP pull-down from 293FT cells transfected with GFP-tagged full-length MDC1 and either control siRNA (siCtrl) or siRNA against CIP2A (siCIP2A). All scale bars = 10 µm. Source data are provided as a Source Data file.
Pp2a Inhibition, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/pmc09288427-227-41-46?v=Selleck+Chemicals
Average 94 stars, based on 1 article reviews
pp2a inhibition - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology pp2a inhibition okadaic acid
a) Co-depletion of ENSA and ARPP19 proteins in the MDA-MB-231 cell line using specific siRNAs or control siRNAs against luciferase ( Luc ). 72 h after transfection cells were starved for glucose for 1 h and re-stimulated with glucose for 15 min. Total cell extracts were collected and analyzed for the indicated antibodies. b) isgMASTL cells were previously infected with lentiviral supernatants expressing FLAG- and HA-tagged versions of ENSA and ARPP19 phospho-mimetic mutants (S67D and S62D) or GFP as a control. Cells were treated with Dox to induce MASTL CRISPR/Cas9-dependent knock-out, and 72 h later cells were treated as specified in a) . c) Control (Dox −) and MASTL knockout (Dox +) cells were treated with 5 μM fostriecin, 50 nM <t>okadaic</t> acid (OA) or vehicle (Veh) 10 min before insulin stimulation for 30 min. Total lysates were analyzed for the indicated antibodies. Histograms in b, c, represents the quantification of phospho-AKT T308 from 3 independent experiments. Data are mean ± s.e.m. * P <0.05; paired Student’s t -test.
Pp2a Inhibition Okadaic Acid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/bio_rxiv__2020__11__26__399915-192-1-8?v=Santa+Cruz+Biotechnology
Average 95 stars, based on 1 article reviews
pp2a inhibition okadaic acid - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Mochida Pharmaceutical inhibition of pp2a-b55
a) Co-depletion of ENSA and ARPP19 proteins in the MDA-MB-231 cell line using specific siRNAs or control siRNAs against luciferase ( Luc ). 72 h after transfection cells were starved for glucose for 1 h and re-stimulated with glucose for 15 min. Total cell extracts were collected and analyzed for the indicated antibodies. b) isgMASTL cells were previously infected with lentiviral supernatants expressing FLAG- and HA-tagged versions of ENSA and ARPP19 phospho-mimetic mutants (S67D and S62D) or GFP as a control. Cells were treated with Dox to induce MASTL CRISPR/Cas9-dependent knock-out, and 72 h later cells were treated as specified in a) . c) Control (Dox −) and MASTL knockout (Dox +) cells were treated with 5 μM fostriecin, 50 nM <t>okadaic</t> acid (OA) or vehicle (Veh) 10 min before insulin stimulation for 30 min. Total lysates were analyzed for the indicated antibodies. Histograms in b, c, represents the quantification of phospho-AKT T308 from 3 independent experiments. Data are mean ± s.e.m. * P <0.05; paired Student’s t -test.
Inhibition Of Pp2a B55, supplied by Mochida Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/10__7554_slash_elife__59885-31-2-24?v=Mochida+Pharmaceutical
Average 90 stars, based on 1 article reviews
inhibition of pp2a-b55 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Merck KGaA okadaic acid (oa; 10 nm; a concentration previously shown to inhibit pp2a activity
a) Co-depletion of ENSA and ARPP19 proteins in the MDA-MB-231 cell line using specific siRNAs or control siRNAs against luciferase ( Luc ). 72 h after transfection cells were starved for glucose for 1 h and re-stimulated with glucose for 15 min. Total cell extracts were collected and analyzed for the indicated antibodies. b) isgMASTL cells were previously infected with lentiviral supernatants expressing FLAG- and HA-tagged versions of ENSA and ARPP19 phospho-mimetic mutants (S67D and S62D) or GFP as a control. Cells were treated with Dox to induce MASTL CRISPR/Cas9-dependent knock-out, and 72 h later cells were treated as specified in a) . c) Control (Dox −) and MASTL knockout (Dox +) cells were treated with 5 μM fostriecin, 50 nM <t>okadaic</t> acid (OA) or vehicle (Veh) 10 min before insulin stimulation for 30 min. Total lysates were analyzed for the indicated antibodies. Histograms in b, c, represents the quantification of phospho-AKT T308 from 3 independent experiments. Data are mean ± s.e.m. * P <0.05; paired Student’s t -test.
Okadaic Acid (Oa; 10 Nm; A Concentration Previously Shown To Inhibit Pp2a Activity, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/10__1096_slash_fj__201902506r-37-27-42?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
okadaic acid (oa; 10 nm; a concentration previously shown to inhibit pp2a activity - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
National Research Council Canada abraxis protein phosphate inhibition (pp2a) assay
Recovery of certified reference materials from National Research Council of Canada used in multiple analyses to validate <t> protein phosphate inhibition (PP2A) assay </t> kit purchased from <t> Abraxis. </t> CRM, certified reference material; mus-c, contaminated mussel.
Abraxis Protein Phosphate Inhibition (Pp2a) Assay, supplied by National Research Council Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pp2a+inhibition/pmc05793076-188-4-19?v=National+Research+Council+Canada
Average 90 stars, based on 1 article reviews
abraxis protein phosphate inhibition (pp2a) assay - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


a Western blots of total cell extract of RPE-1 wild type cells (WT) and RPE-1 CIP2A knock-out cells cells (ΔCIP2A) either Mock treated (-) or treated with the PP2A inhibitor LB-100. b GFP pull-down from 293FT cells transfected with GFP-tagged full-length MDC1 and either control siRNA (siCtrl) or siRNA against CIP2A (siCIP2A). All scale bars = 10 µm. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis

doi: 10.1038/s41467-022-31865-5

Figure Lengend Snippet: a Western blots of total cell extract of RPE-1 wild type cells (WT) and RPE-1 CIP2A knock-out cells cells (ΔCIP2A) either Mock treated (-) or treated with the PP2A inhibitor LB-100. b GFP pull-down from 293FT cells transfected with GFP-tagged full-length MDC1 and either control siRNA (siCtrl) or siRNA against CIP2A (siCIP2A). All scale bars = 10 µm. Source data are provided as a Source Data file.

Article Snippet: For cell synchronization in pro-metaphase, cells were incubated with 5 μg/ml Nocodazole (Sigma-Aldrich, M1404) for 16 h. For CRM1 inhibition, 10 μM Leptomycin B (Apollo Scientific) or 10 μM Selinexor (Focus Biomolecules) were added to the medium for 3 h. For PP2A inhibition, 10 nM LB-100 (Selleckchem, S7537) was added for 2 h. mCherry-Fok1 DSB-reporter was induced by treatment with 1 μM Shield-1 and 1 μM 4-hydroxytamoxifen (4-OHT) for 4 h. Irradiation of cells was done in a YXLON, Y.SMART583 custom-made X-ray device or a Faxitron 43855D irradiator.

Techniques: Western Blot, Knock-Out, Transfection, Control

a) Co-depletion of ENSA and ARPP19 proteins in the MDA-MB-231 cell line using specific siRNAs or control siRNAs against luciferase ( Luc ). 72 h after transfection cells were starved for glucose for 1 h and re-stimulated with glucose for 15 min. Total cell extracts were collected and analyzed for the indicated antibodies. b) isgMASTL cells were previously infected with lentiviral supernatants expressing FLAG- and HA-tagged versions of ENSA and ARPP19 phospho-mimetic mutants (S67D and S62D) or GFP as a control. Cells were treated with Dox to induce MASTL CRISPR/Cas9-dependent knock-out, and 72 h later cells were treated as specified in a) . c) Control (Dox −) and MASTL knockout (Dox +) cells were treated with 5 μM fostriecin, 50 nM okadaic acid (OA) or vehicle (Veh) 10 min before insulin stimulation for 30 min. Total lysates were analyzed for the indicated antibodies. Histograms in b, c, represents the quantification of phospho-AKT T308 from 3 independent experiments. Data are mean ± s.e.m. * P <0.05; paired Student’s t -test.

Journal: bioRxiv

Article Title: A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner

doi: 10.1101/2020.11.26.399915

Figure Lengend Snippet: a) Co-depletion of ENSA and ARPP19 proteins in the MDA-MB-231 cell line using specific siRNAs or control siRNAs against luciferase ( Luc ). 72 h after transfection cells were starved for glucose for 1 h and re-stimulated with glucose for 15 min. Total cell extracts were collected and analyzed for the indicated antibodies. b) isgMASTL cells were previously infected with lentiviral supernatants expressing FLAG- and HA-tagged versions of ENSA and ARPP19 phospho-mimetic mutants (S67D and S62D) or GFP as a control. Cells were treated with Dox to induce MASTL CRISPR/Cas9-dependent knock-out, and 72 h later cells were treated as specified in a) . c) Control (Dox −) and MASTL knockout (Dox +) cells were treated with 5 μM fostriecin, 50 nM okadaic acid (OA) or vehicle (Veh) 10 min before insulin stimulation for 30 min. Total lysates were analyzed for the indicated antibodies. Histograms in b, c, represents the quantification of phospho-AKT T308 from 3 independent experiments. Data are mean ± s.e.m. * P <0.05; paired Student’s t -test.

Article Snippet: For PP2A inhibition okadaic acid (Calbiochem) and fostriecin (Santa Cruz Biotechnologies) were used at 50 nM and 5 μM, respectively.

Techniques: Control, Luciferase, Transfection, Infection, Expressing, CRISPR, Knock-Out

Recovery of certified reference materials from National Research Council of Canada used in multiple analyses to validate  protein phosphate inhibition (PP2A) assay  kit purchased from  Abraxis.  CRM, certified reference material; mus-c, contaminated mussel.

Journal: Marine Drugs

Article Title: Evaluation of Rapid, Early Warning Approaches to Track Shellfish Toxins Associated with Dinophysis and Alexandrium Blooms

doi: 10.3390/md16010028

Figure Lengend Snippet: Recovery of certified reference materials from National Research Council of Canada used in multiple analyses to validate protein phosphate inhibition (PP2A) assay kit purchased from Abraxis. CRM, certified reference material; mus-c, contaminated mussel.

Article Snippet: The use of the Abraxis protein phosphate inhibition (PP2A) assay was validated using certified reference materials purchased from the National Research Council of Canada, with reference materials including a naturally-contaminated mussel sample (CRM-DSP-mus-c) and a methanolic calibration standard, yielding recoveries between 100% and 113% and a certified non-toxic mussel homogenate (CRM-zero-mus) yielding concentrations below methodological detection limits ( ).

Techniques: Inhibition

Total DSP toxins (ng g −1 ) in wild shellfish harvested from regions of New York. Comparison of two extraction methods (double exhaustive and single dispersive) and comparison of two analytical methods (protein phosphatase inhibition assay, PP2A; and liquid chromatography mass spectrometry, LC/MS). Bold indicates over the federal closure limit (160 ng g −1 ).

Journal: Marine Drugs

Article Title: Evaluation of Rapid, Early Warning Approaches to Track Shellfish Toxins Associated with Dinophysis and Alexandrium Blooms

doi: 10.3390/md16010028

Figure Lengend Snippet: Total DSP toxins (ng g −1 ) in wild shellfish harvested from regions of New York. Comparison of two extraction methods (double exhaustive and single dispersive) and comparison of two analytical methods (protein phosphatase inhibition assay, PP2A; and liquid chromatography mass spectrometry, LC/MS). Bold indicates over the federal closure limit (160 ng g −1 ).

Article Snippet: The use of the Abraxis protein phosphate inhibition (PP2A) assay was validated using certified reference materials purchased from the National Research Council of Canada, with reference materials including a naturally-contaminated mussel sample (CRM-DSP-mus-c) and a methanolic calibration standard, yielding recoveries between 100% and 113% and a certified non-toxic mussel homogenate (CRM-zero-mus) yielding concentrations below methodological detection limits ( ).

Techniques: Comparison, Extraction, Inhibition, Liquid Chromatography, Mass Spectrometry

Total DSP toxins (ng g −1 ) in ( A ) softshell clams ( n = 9) and ( B ) various shellfish species ( n = 6) from New York embayments analyzed via LCMS and PP2A. Each point represents >6 pooled individuals.

Journal: Marine Drugs

Article Title: Evaluation of Rapid, Early Warning Approaches to Track Shellfish Toxins Associated with Dinophysis and Alexandrium Blooms

doi: 10.3390/md16010028

Figure Lengend Snippet: Total DSP toxins (ng g −1 ) in ( A ) softshell clams ( n = 9) and ( B ) various shellfish species ( n = 6) from New York embayments analyzed via LCMS and PP2A. Each point represents >6 pooled individuals.

Article Snippet: The use of the Abraxis protein phosphate inhibition (PP2A) assay was validated using certified reference materials purchased from the National Research Council of Canada, with reference materials including a naturally-contaminated mussel sample (CRM-DSP-mus-c) and a methanolic calibration standard, yielding recoveries between 100% and 113% and a certified non-toxic mussel homogenate (CRM-zero-mus) yielding concentrations below methodological detection limits ( ).

Techniques: